semaglutide
Showing 26 - 50 of 191
Diabetes, Type 2 Trial (Semaglutide, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo
- (no location specified)
Jul 31, 2022
Alzheimers Disease Trial in Worldwide (Semaglutide, Placebo)
Not yet recruiting
- Alzheimers Disease
- Semaglutide
- Placebo
-
Sun City, Arizona
- +8 more
May 29, 2023
Schizophrenia Spectrum Disorders Trial in Toronto (Semaglutide, Placebo)
Recruiting
- Schizophrenia Spectrum Disorders
- Semaglutide
- Placebo
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jun 27, 2022
(rPMS) Study of Ozempic to Evaluate Safety and Effectiveness in
Not yet recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- (no location specified)
Jan 17, 2023
Looking at How Oral Semaglutide Works in People With Type 2
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Semaglutide
-
Paris, La Défense, FranceNovo Nordisk Investigational Site
Nov 23, 2022
Type 1 Diabetes, Obesity Trial in United States (Semaglutide, Placebo)
Not yet recruiting
- Type 1 Diabetes
- Obesity
- Semaglutide
- Placebo
-
Aurora, Colorado
- +3 more
Sep 8, 2022
Looking at How Oral Semaglutide Works in People With Type 2
Recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
-
Barcelona, Spain
- +1 more
Nov 10, 2022
Obesity Trial in Anaheim (PF-07081532, Semaglutide)
Recruiting
- Obesity
- PF-07081532
- Semaglutide
-
Anaheim, CaliforniaAnaheim Clinical Trials, LLC
Jan 27, 2023
Obesity Trial in Loma Linda (Semaglutide, Orlistat, Phentermine/Topiramate)
Recruiting
- Obesity
- Semaglutide
- +4 more
-
Loma Linda, CaliforniaNovo Nordisk Investigational Site
Jan 24, 2023
Looking at How Oral Semaglutide Works in People With Type 2
Recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
-
Guadalajara, Jalisco, Mexico
- +1 more
Nov 10, 2022
Understand How Oral Semaglutide Works in People With Type 2
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Semaglutide
-
Bologna, Italy
- +17 more
Feb 23, 2023
Diabetes, Type 2 Trial in Beijing (IcoSema, insulin icodec, semaglutide)
Recruiting
- Diabetes Mellitus, Type 2
- IcoSema
- +2 more
-
Beijing, Beijing, ChinaNovo Nordisk Investigational Site
Jun 23, 2022
Diabetes, Type 2 Trial in Czechia, Thailand (Insulin Icodec, Semaglutide)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Insulin Icodec
- Semaglutide
-
Broumov, Czechia
- +7 more
Apr 3, 2023
Obesity Trial in Worldwide (Semaglutide, Placebo)
Not yet recruiting
- Obesity
- Semaglutide
- Placebo
-
Innsbruck, Austria
- +13 more
Feb 3, 2023
Type2 Diabetes Trial in Malmö (Semaglutide, Dapagliflozin)
Active, not recruiting
- Type2 Diabetes
- Semaglutide
- Dapagliflozin
-
Malmö, Skane, SwedenAnders Rosengrentest
Mar 25, 2022
Type 2 Diabetes Trial in Cleveland (Semaglutide, Insulin Degludec, Insulin aspart)
Recruiting
- Type 2 Diabetes
- Semaglutide
- +2 more
-
Cleveland, OhioCleveland Clinic
Jul 18, 2022
Healthy Volunteers, Overweight, Obesity Trial in Groningen (NNC0480-0389, Semaglutide, Placebo (NNC0480-0389))
Completed
- Healthy Volunteers
- +3 more
- NNC0480-0389
- +3 more
-
Groningen, NetherlandsNovo Nordisk Investigational Site
Mar 23, 2022
Idiopathic Intracranial Hypertension, Intracranial Pressure, Obesity Trial in Glostrup, Odense (drug, dietary supplement,
Recruiting
- Idiopathic Intracranial Hypertension
- +5 more
- Semaglutide
- +2 more
-
Glostrup, Denmark
- +1 more
Sep 7, 2023
Overweight, Obesity Trial in China, Taiwan (Semaglutide, Placebo)
Recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo
-
Beijing, Beijing, China
- +19 more
Sep 20, 2023
Type 2 Diabetes, Chronic Inflammation, Intestinal Permeability Trial in Aurora (Semaglutide, Placebo)
Recruiting
- Type 2 Diabetes
- +2 more
- Semaglutide
- Placebo
-
Aurora, ColoradoUniversity of Colorado Anschutz
Apr 12, 2022
Atrial Fibrillation, Obesity, Overweight Trial in San Francisco (Semaglutide, Placebo)
Not yet recruiting
- Atrial Fibrillation
- +2 more
- Semaglutide
- Placebo
-
San Francisco, CaliforniaVeterans Affairs Medical Center San Francisco
Jan 25, 2022
Overweight, Obesity Trial (Semaglutide, Placebo semaglutide)
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo semaglutide
-
Birmingham, Alabama
- +21 more
Jan 24, 2023
Obesity Trial (drug, dietary supplement, behavioral)
Not yet recruiting
- Obesity
- IV bimagrumab
- +4 more
- (no location specified)
Jun 27, 2023
Diabetes, Type 2 Trial in Washington (Semaglutide, Placebos)
Recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebos
-
Washington, District of ColumbiaThe GW Medical Faculty Associates
Mar 21, 2022